Assisted NC businesses in winning 2,630 contracts valued up to $25.81 billion

BARDA (DHHS) Acting Deputy Director to attend Support to the Warfighter Symposium (June 14 – Chapel Hill, NC) – Registration Open

DR. JOE LARSEN (BARDA) TO PRESENT AT MEDICAL, BIOMEDICAL & BIODEFENSE (MBB): SUPPORT TO THE WARFIGHTER SYMPOSIUM

The Offices of United States Senator Richard Burr and United States Senator Thom Tillis, the North Carolina Military Business Center, the North Carolina Biotechnology Center and the University of North Carolina are pleased to host the Medical, Biomedical & Biodefense: Support to the Warfighter Symposium on June 14 in Chapel Hill, North Carolina.

GOLD SPONSOR

SILVER SPONSORS

BRONZE SPONSOR
FIRST CHOICE MEDICAL, INC.

SMALL BUSINESS SPONSORS

EarlySense
Gamma Advanced Technology
WHEN.  June 14, 2017
WHERE.  University of North Carolina – Chapel Hill
The Friday Conference Center
100 Friday Center Drive
Chapel Hill, North Carolina  27599

Website: For more information or to register, visit: http://www.ncmbc.us/17mbb/.

 
JOE LARSEN, PH.D.

Acting Deputy Director
Biomedical Advanced Research and Development Authority (BARDA)
Office of the Assistant Secretary for Preparedness and Response
U.S. Department of Health and Human Services

Dr. Larsen is acting Deputy Director of the Biomedical Advanced Research Development Authority (BARDA). He previously served as Deputy Director of BARDA’s Chemical, Biological, Radiological, and Nuclear Medical Countermeasure Division where he oversaw a $2.8B fund for the procurement of medical products for use during public health emergencies. He is also the BARDA lead for the Obama Administration’s Initiative on combating antibiotic resistant bacteria and has chaired intergovernmental working groups on research and development and economic incentives for antibacterial drug development. Previously Dr. Larsen served as Chief of the Broad Spectrum Antimicrobials program at BARDA. The goal of BARDA’s Broad Spectrum Antimicrobials program is to develop additional antimicrobial treatment options needed to counter the growing threat of antimicrobial resistance. In that role, he oversaw a portfolio of approximately $1.2B in programs that support the development of novel antibacterial and antiviral drugs. Dr. Larsen also serves as the BARDA representative on the U.S. Transatlantic Task Force on Antimicrobial Resistance.

Previously, Dr. Larsen served as a Senior Science and Technology Manager at the Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBDP) within the Defense Threat Reduction Agency (DTRA). There, he managed a ~$50M applied research program aimed at the development of medical therapeutics against viral, bacterial, and toxin threat agents. From 2005-2006, Dr. Larsen was an American Association for the Advancement of Science (AAAS) fellow at the Department of Homeland Security. There, he managed University based research programs aimed at the development enhanced food safety detection systems and medical countermeasures for agricultural threat agents.

Joe was a 2005 National Academy of Science Christine Mirzayan fellow with the Board of Life Sciences. Dr. Larsen received his PhD in Microbiology from the Uniformed Services University of the Health Sciences and his BA with honors from the University of Kansas.


The NC Military Business Center, the NC Community College System, and the State of North Carolina do not officially endorse events. These items are posted strictly for the information and convenience of NCMBC customers.

website by Biz Tools One